180 related articles for article (PubMed ID: 30347681)
21. Effects of betulinic acid on proliferation and apoptosis in Jurkat cells and its in vitro mechanism.
Chen Z; Wu Q; Chen Y; He J
J Huazhong Univ Sci Technolog Med Sci; 2008 Dec; 28(6):634-8. PubMed ID: 19107355
[TBL] [Abstract][Full Text] [Related]
22. Effects of betulinic acid alone and in combination with irradiation in human melanoma cells.
Selzer E; Pimentel E; Wacheck V; Schlegel W; Pehamberger H; Jansen B; Kodym R
J Invest Dermatol; 2000 May; 114(5):935-40. PubMed ID: 10771474
[TBL] [Abstract][Full Text] [Related]
23. Betulinic acid, a major therapeutic triterpene of Celastrus orbiculatus Thunb., acts as a chemosensitizer of gemcitabine by promoting Chk1 degradation.
Tao L; Zhou K; Zhao Y; Xia X; Guo Y; Gao Y; Peng G; Liu Y
J Ethnopharmacol; 2023 Jun; 309():116295. PubMed ID: 36813244
[TBL] [Abstract][Full Text] [Related]
24. Pristimerin causes G1 arrest, induces apoptosis, and enhances the chemosensitivity to gemcitabine in pancreatic cancer cells.
Wang Y; Zhou Y; Zhou H; Jia G; Liu J; Han B; Cheng Z; Jiang H; Pan S; Sun B
PLoS One; 2012; 7(8):e43826. PubMed ID: 22952775
[TBL] [Abstract][Full Text] [Related]
25. Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells.
Veschi S; De Lellis L; Florio R; Lanuti P; Massucci A; Tinari N; De Tursi M; di Sebastiano P; Marchisio M; Natoli C; Cama A
J Exp Clin Cancer Res; 2018 Sep; 37(1):236. PubMed ID: 30241558
[TBL] [Abstract][Full Text] [Related]
26. [Effect of betulinic acid on proliferation and apoptosis in Jurkat cells and its mechanism].
Chen Z; Wu QL; Chen Y; He J
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):588-92. PubMed ID: 19102935
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of phosphotidylinositol-3 kinase pathway by a novel naphthol derivative of betulinic acid induces cell cycle arrest and apoptosis in cancer cells of different origin.
Majeed R; Hamid A; Sangwan PL; Chinthakindi PK; Koul S; Rayees S; Singh G; Mondhe DM; Mintoo MJ; Singh SK; Rath SK; Saxena AK
Cell Death Dis; 2014 Oct; 5(10):e1459. PubMed ID: 25299784
[TBL] [Abstract][Full Text] [Related]
28. [Effect of betulinic acid on inducing apoptosis of human multiple myeloma cell line RPMI-8226].
Cheng YQ; Chen Y; Wu QL; Fang J; Yang LJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1224-9. PubMed ID: 19840455
[TBL] [Abstract][Full Text] [Related]
29. Betulinic acid-mediating miRNA-365 inhibited the progression of pancreatic cancer.
Li X; Jiang W; Li W; Dong S; DU Y; Zhang H; Zhou W
Oncol Res; 2023; 31(4):505-514. PubMed ID: 37415745
[TBL] [Abstract][Full Text] [Related]
30. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
31. Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status.
Broecker-Preuss M; Müller S; Britten M; Worm K; Schmid KW; Mann K; Fuhrer D
BMC Cancer; 2015 Mar; 15():184. PubMed ID: 25879531
[TBL] [Abstract][Full Text] [Related]
32. Combining betulinic acid and mithramycin a effectively suppresses pancreatic cancer by inhibiting proliferation, invasion, and angiogenesis.
Gao Y; Jia Z; Kong X; Li Q; Chang DZ; Wei D; Le X; Suyun H; Huang S; Wang L; Xie K
Cancer Res; 2011 Aug; 71(15):5182-93. PubMed ID: 21673052
[TBL] [Abstract][Full Text] [Related]
33. Transient activation of EGFR/AKT cell survival pathway and expression of survivin contribute to reduced sensitivity of human melanoma cells to betulinic acid.
Qiu L; Wang Q; Di W; Jiang Q; Schefeller E; Derby S; Wanebo H; Yan B; Wan Y
Int J Oncol; 2005 Sep; 27(3):823-30. PubMed ID: 16077934
[TBL] [Abstract][Full Text] [Related]
34. Betulinic Acid Inhibits Cell Proliferation in Human Oral Squamous Cell Carcinoma via Modulating ROS-Regulated p53 Signaling.
Shen H; Liu L; Yang Y; Xun W; Wei K; Zeng G
Oncol Res; 2017 Aug; 25(7):1141-1152. PubMed ID: 28109089
[TBL] [Abstract][Full Text] [Related]
35. Betulinic acid derivative BA5, a dual NF-kB/calcineurin inhibitor, alleviates experimental shock and delayed hypersensitivity.
Meira CS; Espírito Santo RFD; Dos Santos TB; Orge ID; Silva DKC; Guimarães ET; Aragão França LS; Barbosa-Filho JM; Moreira DRM; Soares MBP
Eur J Pharmacol; 2017 Nov; 815():156-165. PubMed ID: 28899698
[TBL] [Abstract][Full Text] [Related]
36. Induction of cell death in pancreatic ductal adenocarcinoma by indirubin 3'-oxime and 5-methoxyindirubin 3'-oxime in vitro and in vivo.
Sano M; Ichimaru Y; Kurita M; Hayashi E; Homma T; Saito H; Masuda S; Nemoto N; Hemmi A; Suzuki T; Miyairi S; Hao H
Cancer Lett; 2017 Jul; 397():72-82. PubMed ID: 28347789
[TBL] [Abstract][Full Text] [Related]
37. Lupeol inhibits proliferation and induces apoptosis of human pancreatic cancer PCNA-1 cells through AKT/ERK pathways.
Liu Y; Bi T; Wang G; Dai W; Wu G; Qian L; Gao Q; Shen G
Naunyn Schmiedebergs Arch Pharmacol; 2015 Mar; 388(3):295-304. PubMed ID: 25418891
[TBL] [Abstract][Full Text] [Related]
38. [Effect of betulinic acid on proliferation of human gastric cancer SGC-7901 cells].
Chen YN; Shao SL; He MQ; Huang X; Zhang WW; Zhang ZZ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Nov; 36(6):628-632. PubMed ID: 33719271
[No Abstract] [Full Text] [Related]
39. Combined targeting of histone deacetylases and hedgehog signaling enhances cytoxicity in pancreatic cancer.
Chun SG; Zhou W; Yee NS
Cancer Biol Ther; 2009 Jul; 8(14):1328-39. PubMed ID: 19421011
[TBL] [Abstract][Full Text] [Related]
40. Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10.
Mertens-Talcott SU; Noratto GD; Li X; Angel-Morales G; Bertoldi MC; Safe S
Mol Carcinog; 2013 Aug; 52(8):591-602. PubMed ID: 22407812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
